Panacea Biotec receives prestigious Intellectual Property & Science Award for the year 2015

30 Mar 2016 Evaluate

Panacea Biotec has received prestigious Thomson Reuters Intellectual Property & Science Award for the year 2015 as ‘Top 50 Indian Innovators - 2015’. Thomson Reuters India Innovation Awards honors the most innovative academic institutions and commercial enterprises headquartered in India for their spirit of innovation in R&D as it relates to Indian patent publications. Thomson Reuters has identified top 50 Indian Innovators across the Indian industry.

Thomson Reuters 2015 India Innovation Awards is based on research and analysis done using the Derwent World Patents Index, the world's most trusted and authoritative value-added patent database. Data from 2010-2014 was used for the analysis for the Indian companies. The threshold for inclusion in the Top 50 Indian innovators is at least 25 patents published during the period 2010-2014.

Panacea Biotec is the third largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.

Panacea Biotec Share Price

384.70 -7.35 (-1.87%)
20-Jan-2026 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.15
Dr. Reddys Lab 1175.25
Cipla 1380.40
Zydus Lifesciences 876.45
Lupin 2170.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×